Adhesives maker H.B. Fuller's Q4 revenue slightly misses expectations

Reuters
01/15
Adhesives maker H.B. Fuller's Q4 revenue slightly misses expectations

Overview

  • Adhesives firm's Q4 revenue slightly missed analysts' expectations

  • Adjusted EPS for Q4 beat analysts' expectations

  • Adjusted net income for Q4 beat analyst expectations

Outlook

  • H.B. Fuller expects fiscal 2026 net revenue to be flat to up 2%

  • Company anticipates fiscal 2026 adjusted EBITDA between $630 mln and $660 mln

  • H.B. Fuller projects fiscal 2026 adjusted EPS between $4.35 and $4.70

Result Drivers

  • PRICING AND COST ACTIONS - Adjusted gross margin increased 290 basis points year-on-year due to favorable pricing and raw material cost actions

  • COST SAVINGS - SG&A expenses decreased modestly year-on-year due to continued cost-saving efforts and lower variable compensation

  • REVENUE IMPACT OF DIVESTITURE - Net revenue was down 3.1% year-on-year, but adjusting for the flooring divestiture, net revenue was up 0.9% year-on-year

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Slight Miss*

$895 mln

$902.51 mln (7 Analysts)

Q4 Adjusted EPS

Beat

$1.28

$1.23 (7 Analysts)

Q4 Adjusted Net Income

Beat

$71 mln

$67.52 mln (6 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for H.B. Fuller Company is $70.50, about 6.3% above its January 13 closing price of $66.30

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nBw3RMzkJa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10